MARKULAN, L.; MAKAREVYCH, L. Pembrolizumab as an immunotherapy drug in the treatment of a patient with recurrent (unresectable) cancer of the lower lip. General Surgery, [S. l.], n. 2, p. 75–82, 2022. DOI: 10.30978/GS-2022-2-75. Disponível em: http://generalsurgery.com.ua/article/view/270978. Acesso em: 24 nov. 2024.